ATE383425T1 - Virulenzgene und deren proteine und verwendungen - Google Patents

Virulenzgene und deren proteine und verwendungen

Info

Publication number
ATE383425T1
ATE383425T1 AT99954184T AT99954184T ATE383425T1 AT E383425 T1 ATE383425 T1 AT E383425T1 AT 99954184 T AT99954184 T AT 99954184T AT 99954184 T AT99954184 T AT 99954184T AT E383425 T1 ATE383425 T1 AT E383425T1
Authority
AT
Austria
Prior art keywords
proteins
virulence genes
identification
genes
products
Prior art date
Application number
AT99954184T
Other languages
English (en)
Inventor
Helen Rachel Crooke
Enda Elizabeth Clarke
Paul Howard Everest
Gordon Dougan
David William Holden
Jacqueline Elizabeth Shea
Robert Graham Feldman
Original Assignee
Microscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9824569.9A external-priority patent/GB9824569D0/en
Priority claimed from GBGB9824570.7A external-priority patent/GB9824570D0/en
Priority claimed from GBGB9827814.6A external-priority patent/GB9827814D0/en
Priority claimed from GBGB9827815.3A external-priority patent/GB9827815D0/en
Priority claimed from GBGB9827816.1A external-priority patent/GB9827816D0/en
Priority claimed from GBGB9827818.7A external-priority patent/GB9827818D0/en
Priority claimed from GBGB9901915.0A external-priority patent/GB9901915D0/en
Application filed by Microscience Ltd filed Critical Microscience Ltd
Application granted granted Critical
Publication of ATE383425T1 publication Critical patent/ATE383425T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/30—Signal or leader sequence
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/31—Linker sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AT99954184T 1998-11-09 1999-11-09 Virulenzgene und deren proteine und verwendungen ATE383425T1 (de)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
GBGB9824569.9A GB9824569D0 (en) 1998-11-09 1998-11-09 Virulence gene and protein,and their use
GBGB9824570.7A GB9824570D0 (en) 1998-11-09 1998-11-09 Virulence gene and protein,and their use
GBGB9827814.6A GB9827814D0 (en) 1998-12-17 1998-12-17 Virulence gene and protein and their use
GBGB9827815.3A GB9827815D0 (en) 1998-12-17 1998-12-17 Virulence gene and protein,and their use
GBGB9827816.1A GB9827816D0 (en) 1998-12-17 1998-12-17 Virulence gene and protein,and their use
GBGB9827818.7A GB9827818D0 (en) 1998-12-17 1998-12-17 Virulence gene and protein,and their use
GB9900710 1999-01-13
GB9900711 1999-01-13
GB9900708 1999-01-13
GBGB9901915.0A GB9901915D0 (en) 1999-01-28 1999-01-28 Virulence gene and protein,and their use

Publications (1)

Publication Number Publication Date
ATE383425T1 true ATE383425T1 (de) 2008-01-15

Family

ID=27579424

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99954184T ATE383425T1 (de) 1998-11-09 1999-11-09 Virulenzgene und deren proteine und verwendungen

Country Status (12)

Country Link
US (2) US6846667B1 (de)
EP (2) EP1129196B1 (de)
JP (1) JP2002529091A (de)
KR (1) KR20010099789A (de)
CN (2) CN1196787C (de)
AT (1) ATE383425T1 (de)
AU (1) AU773003B2 (de)
BR (1) BR9915165A (de)
CA (1) CA2348699A1 (de)
DE (1) DE69937965T2 (de)
NZ (2) NZ527279A (de)
WO (1) WO2000028038A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69526377T2 (de) * 1994-12-09 2002-11-07 Microscience Ltd Virulenzgene in der VGC2-Region von Salmonella
WO2000014240A2 (en) * 1998-09-04 2000-03-16 Creatogen Aktiengesellschaft Attenuated salmonella sp12 mutants as antigen carriers
GB9910812D0 (en) * 1999-05-10 1999-07-07 Microscience Ltd Vaccine composition
GB0012079D0 (en) * 2000-05-18 2000-07-12 Microscience Ltd Virulence gene and protein, and their use
FR2842210B1 (fr) * 2002-07-09 2012-12-14 Mutabilis Determinants de pathogenicite utilisables comme cibles pour l'elaboration de moyens de prevention et de controle d'infections bacteriennes et/ou de la dissemination systemique
US7078165B2 (en) * 2003-03-27 2006-07-18 Institut Pasteur Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof
US8703153B2 (en) 2008-06-16 2014-04-22 Prokarium Ltd. Salmonella vectored vaccines against Chlamydia and methods of use
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
CN113520895B (zh) * 2021-07-30 2023-05-02 中国科学院大学 一种环保免洗消毒洗手液及其制备方法

Also Published As

Publication number Publication date
WO2000028038A3 (en) 2000-08-31
CA2348699A1 (en) 2000-05-18
DE69937965D1 (de) 2008-02-21
US6846667B1 (en) 2005-01-25
JP2002529091A (ja) 2002-09-10
US20050142149A1 (en) 2005-06-30
AU773003B2 (en) 2004-05-13
KR20010099789A (ko) 2001-11-09
EP1129196A2 (de) 2001-09-05
NZ527279A (en) 2005-05-27
NZ511366A (en) 2004-03-26
WO2000028038A2 (en) 2000-05-18
AU1060500A (en) 2000-05-29
CN1524575A (zh) 2004-09-01
EP1914312A2 (de) 2008-04-23
BR9915165A (pt) 2001-12-04
CN1264568C (zh) 2006-07-19
CN1330714A (zh) 2002-01-09
EP1129196B1 (de) 2008-01-09
EP1914312A3 (de) 2008-10-08
DE69937965T2 (de) 2009-01-08
CN1196787C (zh) 2005-04-13

Similar Documents

Publication Publication Date Title
DE68917163D1 (de) Antibakterielle Mittel.
DE69937965D1 (de) Virulenzgene und deren proteine und verwendungen
ATE382094T1 (de) Primer, sätze und restriktions fragmente und dessen benutzung in selektive restriktionsfragmentenamplifikation
ATE172984T1 (de) Nukleinsäuren-bindende oligomere mit n- verzweigung für therapie und diagnostik
ATE190357T1 (de) Schnelles verfahren fur die dns sequenzierung und diagnostische anwendungen
ATE71802T1 (de) Mikroorganismusstamm mit antimicrobieller wirkung.
ATE532877T1 (de) Nukleinsäuremoleküle zum nachweis von bakterien und phylogenetischen einheiten von bakterien
DE69232693D1 (de) Glialmitogene faktoren, ihre herstellung und verwendung
DE60126495D1 (de) Nukleinsäure und protein, genannt 158p1d7, für die behandlung und erkennung von blasenkrebs und anderen krebsarten
DE60132084D1 (de) Virulenz gene, proteine, und ihre verwendung
NO20013102D0 (no) Gener, proteiner og deres anvendelse
ATE99669T1 (de) N-2,3-butadienyl-tri-aminoalkanderivate.
ATE384797T1 (de) Streptococcus pyogenes virulenz gene und proteine und ihre verwendungen
ATE225805T1 (de) Hundecoronavirus s gen und verwendung davon
EA200100701A1 (ru) Белки наружной поверхности, их гены и их применение
ATE403716T1 (de) Nukleinsäure und korrespondierendes protein 85p1b3, nützlich zur behandlung und detektion von krebserkrankungen
DE69431187D1 (de) 14-substituierte marcfortine und derivate als antiparasitäre mittel
ES2066897T3 (es) 5,11-dihidro-6h-pirido(2,3-b)(1,4)benzodiazepin-6-onas y -tionas y su uso en la prevencion o el tratamiento del sida.
ATE354639T1 (de) Virulenz gene, proteine, und ihre verwendung
RU94022337A (ru) Штамм бактерий proteus mirabilis - продуцент термолабильного энтеротоксина
RU94022338A (ru) Штамм бактерий morgunella morganii - продуцент термолабильного энтеротоксина
RU2001132094A (ru) Штамм бактерий Escherichia coli № 28 09:K99, используемый для изготовления вакцин и диагностических препаратов

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties